US 10174018
Protein kinase inhibitors
granted A61KA61K31/506A61K45/06
Quick answer
US patent 10174018 (Protein kinase inhibitors) held by Princeton Drug Discovery, Inc expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Princeton Drug Discovery, Inc
- Grant date
- Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/506, A61K45/06, A61P, A61P25/28